Robert Paul Smith's most recent trade in Gossamer Bio Inc was a trade of 562,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gossamer Bio Inc | Robert Paul Smith | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 562,500 | 562,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Robert Paul Smith | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 93,750 | 260,898 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Robert Paul Smith | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 162,500 | 162,500 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Robert Paul Smith | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 572,000 | 572,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Robert Paul Smith | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 0.60 per share. | 17 Jun 2024 | 25,000 | 25,000 (0%) | 0% | 0.6 | 15,050 | Common Stock |
| Gossamer Bio Inc | Paul Smith Robert | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 1,500,000 | 1,500,000 | - | - | Stock Option (Right to Buy) |